About ExstoBio

Creating the future of personalized cannabinoid therapeutics.

ExstoBio revolutionizes patient care, setting a new standard in cannabinoid therapy through the power of AI.

"I think that [ExstoBio's approach] is probably the future of this whole industry."

Dr. Loc Thang, M.D., Ph.D. Washington University in St. Louis

34%

Industry CAGR
2022-2030

72%

Doctors have been asked about medical cannabis by their patients in the last
30 days.

76%

Doctors approve of medical cannabis.

90%

Doctors feel unequipped to adequately prescribe medical cannabis

The ExstoBio Difference

Comprehensive Approach

Our combination of AI-driven treatment optimization and deep expertise in cannabinoid research sets us apart from traditional approaches and positions us at the forefront of the industry.

We not only focus on providing precise dosage recommendations, we also consider the overall well-being of patients and foster the patient-physician relationship. ExstoAI considers factors such as lifestyle, medical history, and patient feedback to create personalized treatment plans.

Science-based, Data-driven.

By combining AI technology with medical expertise, ExstoBio provides a level of personalization and precision that is unparalleled

Our unique approach allows patients to achieve better outcomes and experience improved quality of life.

Supervised medical cannabis treatment is associated with high-adherence, improvement in QoL, and decrease in pain levels with a low incidence of serious adverse events.

Harm Reduction Journal, 2019. Phillipe Lucas, Eric P. Baron, & Nick Jikomes.

Get helpful, doctor-recommended medical cannabis news and tips delivered to your inbox.

* We respect your privacy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Get useful insight from our team.

* Small disclaimer here about grabbing that sweet data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.